Bio-Rad Reports Q2 2021 Financial Results.
BIO-RAD REPORTS SECOND-QUARTER 2021 FINANCIAL RESULTS.
Q2 NON-GAAP EARNINGS PER SHARE $3.54.
Q2 EARNINGS PER SHARE $30.32.
Q2 SALES ROSE 33.4 PERCENT TO $715.9 MILLION.
SEES 2021 NON-GAAP CURRENCY-NEUTRAL REVENUE GROWTH BETWEEN 10.0 TO 10.5 PERCENT.
